CliffBio
small molecule

CLOBETASOL PROPIONATE

CLOBETASOL PROPIONATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLOBETASOL PROPIONATE
Active ingredientCLOBETASOL PROPIONATE
Strength0.05%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalJanuary 2018
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.